Corpus Intelligence IC Memo — HI - DESERT MEDICAL CENTER 2026-04-26 15:55 UTC
IC Memo — HI - DESERT MEDICAL CENTER
Investment Committee Memorandum | CA | 55 beds | Grade D | EBITDA uplift $5.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HI - DESERT MEDICAL CENTER

CCN 050279 | SAN BERNARDINO, CA | 55 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

HI - DESERT MEDICAL CENTER is a 55-bed suburban community hospital in SAN BERNARDINO, CA with $80.4M in net patient revenue and a 3.7% operating margin. The hospital serves a payer mix of 21.3% Medicare, 5.2% Medicaid, and 73.4% commercial.

Thesis: Turnaround. Our ML models identify $5.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.7% to 11.0% (+736bps).

Net Revenue HCRIS$80.4M
Current EBITDA COMPUTED$3.0M
Operating Margin COMPUTED3.7%
Occupancy HCRIS30.4%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS15.9%
Distress Probability ML50.6%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
109
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 3.7% places it above the state median. Among 109 size-comparable peers (28-110 beds), the median margin is -5.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (28-110), prioritizing same-state peers. 109 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HI - DESERT MEDICAL CENTER (Target)CA55$80.4M3.7%
RANCHO LOS AMIGOS NATL.REHAB.CCA83$512.6M41.9%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
KFH - FREMONTCA100$296.2M-6.6%
MERCY HOSPITAL OF FOLSOMCA106$287.8M17.0%
ADVENTIST HEALTH SONORACA84$274.3M-7.4%
CPMC-R.K. DAVIES MEDICAL CENTECA105$243.7M24.6%
WOODLAND HEALTHCARECA74$211.5M-3.2%
FRENCH HOSPITAL MEDICAL CENTERCA98$208.6M-2.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.7M+210bp18mo
Cost to Collect4.5%2.5%$1.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$979K+122bp9mo
Clean Claim Rate88.0%96.0%$51K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.7M
Cost to Collect
$1.6M
Denial Rate Reduction
$1.6M
A/R Days Reduction
$979K
Clean Claim Rate
$51K
Total EBITDA Uplift$5.9M
Current EBITDA$3.0M
+ RCM Uplift+$5.9M
Pro Forma EBITDA$8.9M
Current Margin3.7%
Pro Forma Margin11.0%
WC Released (1x)$3.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.5M$78.7M17.32x76.9%
Base (11x exit)10.0x11.0x$4.5M$88.0M19.37x80.9%
Bull Case9.0x11.0x$4.1M$109.0M26.66x92.8%
Bull (12x exit)9.0x12.0x$4.1M$120.2M29.38x96.6%
Bear Case11.0x10.0x$5.0M$47.6M9.52x57.0%
Bear (11x exit)11.0x11.0x$5.0M$54.0M10.80x61.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 30.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 109 hospitals with 28-110 beds
  • Same-state prioritization (n=110)
  • Comp margins: P25=-21.6% / P50=-5.9% / P75=1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.